Phase 1 Dermatomyositis trials recruiting now

All Dermatomyositis trials, every phase

Phase 1 Dermatomyositis trials

• Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
  NCT06685042 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
  NCT06347718 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
  NCT06056921 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 260 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.